Figure 9. Immune and pathway characteristics between different risk groups. (A) difference in CIBERSORT immune infiltration between risk subgroups in TCGA cohort; (B) difference in MCP-count, TIMER immune score between risk subgroups in TCGA cohort; (C) correlation between immune score and RiskScore in TCGA cohort; (D) difference in TIDE score and ESTIMATE immune score between risk subgroups in TCGA cohort; (E) difference in drug sensitivity (IC50) between risk subgroups in TCGA cohort.